Research and Development

Showing 15 posts of 9573 posts found.

robert_langer

Puretech Health co-founder and board member Dr Robert Langer wins global engineering prize

October 26, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Dr Robert Langer, Engineering, PureTech Health, Queen Elizabeth engineering prize

Dr Robert Langer, the co-founder of PureTech Health, has won the Queen Elizabeth prize for engineering.The award is in recognition …
amgen_hq

Amgen skin cancer drug gets European approval

October 23, 2015 Research and Development Amgen, Imlygic, melanoma, skin cancer

Amgen’s Imlygic (talimogene laherparepvec) has been approved by the scientific committee of the European Medicines Agency (EMA) for the treatment of adults …
gilead-sciences

Gilead presents Phase III results for Genvoya in HIV

October 22, 2015 Medical Communications, Research and Development Genvoya, Gilead Sciences, HIV

Gilead Sciences has today announced 96-week results from two Phase III studies evaluating its investigational once-daily single tablet regimen (STR), …
bmss_orencia_was_recommended_in_draft_guidance

NICE recommends four treatments for arthritis in children

October 22, 2015 Medical Communications, Research and Development NICE, arthritis, jia

 UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …
bmss_orencia_was_recommended_in_draft_guidance

NICE recommends four treatments for arthritis in children

October 22, 2015 Medical Communications, Research and Development NICE, arthritis, jia

 UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …
uk_china_flags_half_and_half

UK and China sign £2 billion in healthcare trade and investment deals

October 22, 2015 Research and Development

More than £2 billion of healthcare trade deals and collaborations have been signed between Chinese and UK companies, universities, and …
Aspirin

World’s largest clinical trial of aspirin in cancer launches in UK

October 22, 2015 Research and Development CRUK, Cancer, Cancer Research UK, aspirin, clinical trial, phase III

The world’s largest ever clinical trial has been launched across the UK today, to discover whether taking aspirin every day …
Stelera

Encouraging late-stage results for Stelara in Crohn’s disease

October 21, 2015 Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab

Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …
kidney

Featured Market Report – Kidney Disease Global Clinical Trials Review

October 21, 2015 Research and Development

GlobalData’s “Kidney Disease Global Clinical Trials Review, H2, 2015″ gives invaluable insight into the current state of clinical trials in …

Global warning for governments to step up R&D spending

October 21, 2015 Research and Development

Countries should step up their investment in long-term R&D to develop disruptive technologies that will reshape industry, healthcare and communications, …
Humira

Future Focus: The industry’s top five biggest drug patent expirations in 2016

October 21, 2015 Manufacturing and Production, Research and Development biosimilars, blockbuster, generics, patent cliff, patents

From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …
novartis_pic

Novartis acquires Admune Therapeutics

October 21, 2015 Research and Development Admune Therapeutics, Cancer, Novartis, Palobiofarma, immunotherapy

Novartis is broadening its portfolio of cancer immunotherapies with the acquisition of Admune Therapeutics, and signing licensing agreements with Palobiofarma …
nhs_sign

NHS research activity on the rise

October 21, 2015 Research and Development

NHS England has achieved a significant increase in clinical research over the last year, according to new data from The …
dominaix_scientist

Domainex and Imperial College London partner on heart attack treatments

October 20, 2015 Research and Development Domainex cardiac arrest

Drug discovery company Domainex and Imperial College London have announced a new partnership aimed at discovering novel therapies to treat …
nuevolution_logo

Nuevolution, Johnson & Johnson begin discovery collaboration

October 19, 2015 Manufacturing and Production, Research and Development Chemetics, Janssen Biotech, Nuevolution

Nuevolution and Janssen Biotech have entered into a collaboration which will use Nuevolution’s Chemetics drug discovery platform to facilitate discovery …
The Gateway to Local Adoption Series

Latest content